Erkan Topkan, Ahmet Kucuk, Nulifer Kilic Durankus, Sukran Senyurek, Eyub Yasar Akdemir, Duygu Sezen, Esma Didem Ikiz, Yasemin Bolukbasi, Berrin Pehlivan & Ugur Selek·International Research Journal of Oncology·2020
Brainstem metastases account only for 3% to 5% of all intracranial metastasis. However, brainstem metastases undoubtedly represent a significant source of severe morbidity and mortality in affected patients with estimated average survival duration of only less than 6 months. Surg...
Yasemin Bolukbasi, Ugur Selek, Duygu Sezen, Nulifer Kilic Durankus, Eyub Yasar Akdemir, Sukran Senyurek, Ahmet Kucuk, Berrin Pehlivan & Erkan Topkan·Journal of Cancer and Tumor International·2020
Stereotactic radiosurgery (SRS) has been utilized broadly for brain metastases not only for intact ones but as well as of late for the postoperative cavity of metastases after surgery, due to the advantages of SRS to preserve neurocognitive functions, maintain local control and p...
Open access
Research Article10.9734/jcti/2020/v10i230123
Erkan Topkan, Ahmet Kucuk, Sukran Senyurek, Duygu Sezen, Nulifer Kilic Durankus, Eyub Yasar Akdemir, Esma Didem Ikiz, Yasemin Bolukbasi, Berrin Pehlivan & Ugur Selek·Journal of Cancer and Tumor International·2020
Brain metastases (BMs), the most frequent intracranial tumors, are diagnosed in approximately 30% of all adult patients over the span of planned treatment against a broad spectrum of solid cancers. The prognosis of patients presenting with BM is bleak with an expected median OS o...
Open access
Research Article10.9734/jcti/2020/v10i130117